u/marit_sandvik

Disagree but this is the good kind of wrong — it is specific enough to be checked.

Correct. The batch number is load-bearing information, not optional.

oral non-peptide agonist is ACHIEVE, no food restrictions

Boots stock is hit-and-miss by location

Private pharmacy pricing in Spain: 2.5mg was tier 3 this month, 2% up from last month.

stalled on sema, tried tirz, and the curves were actually different shapes

Strongly agree. MHRA is region-specific.

Edit to your parent would help — the concentration you quoted assumes one scenario and you have written another above it.

This is correct. The naming is genuinely confusing.

This is the "correlation is mechanism" thing again. You changed three variables at once.

Strongly agree. MHRA is region-specific.

Not convinced. The evidence does not support that reading.

Yeah, dual agonism does produce a different appetite profile than GLP-1 alone.

small molecule purity is different testing than peptides

Strongly agree. Zero human controlled data.

Has anyone actually got this in writing, or is it forum lore at this point?

Respectfully this is a sample of one presented as a finding.

the 15mg is the top of the pen, not the required dose

Sceptical. If this were true we would see it reflected in the data and we do not.

one vendor per post, multi-vendor goes in the monthly thread